What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
His primary areas of investigation include Internal medicine, Immunology, Lupus erythematosus, Rheumatology and Placebo.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Surgery.
His work carried out in the field of Immunology brings together such families of science as Tolerability and Disease.
The various areas that Daniel J. Wallace examines in his Lupus erythematosus study include Anti-nuclear antibody, Systemic lupus erythematosus, Lupus nephritis and Chemotherapy.
His research integrates issues of Systemic disease, Physical therapy, Biomarker and Clinical significance in his study of Rheumatology.
His studies deal with areas such as Tabalumab, Belimumab, Adverse effect and Randomized controlled trial as well as Placebo.
His most cited work include:
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. (2280 citations)
- The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes (1362 citations)
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus (932 citations)
What are the main themes of his work throughout his whole career to date?
Daniel J. Wallace mainly focuses on Internal medicine, Immunology, Lupus erythematosus, Systemic lupus erythematosus and Rheumatology.
The Internal medicine study combines topics in areas such as Gastroenterology and Placebo.
In his study, Cyclophosphamide is strongly linked to Lupus nephritis, which falls under the umbrella field of Immunology.
His Lupus erythematosus study combines topics in areas such as Surgery, MEDLINE, Belimumab, Disease and Severity of illness.
His Systemic lupus erythematosus research is multidisciplinary, relying on both Dermatology and Intensive care medicine.
His Rheumatology research incorporates themes from Anti-nuclear antibody and Physical therapy.
He most often published in these fields:
- Internal medicine (52.45%)
- Immunology (33.06%)
- Lupus erythematosus (29.80%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (52.45%)
- Lupus erythematosus (29.80%)
- Systemic lupus erythematosus (26.12%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Lupus erythematosus, Systemic lupus erythematosus, Rheumatology and Immunology.
His Internal medicine research integrates issues from Gastroenterology, Placebo and Anti-nuclear antibody.
His work deals with themes such as Monoclonal, Young adult, Dermatology, Disease and Severity of illness, which intersect with Lupus erythematosus.
The study incorporates disciplines such as Medical record, Prospective cohort study, Quality of life and Hazard ratio in addition to Systemic lupus erythematosus.
His Rheumatology study combines topics in areas such as Cohort study, MEDLINE, Autoantibody, Rheumatism and Frailty Index.
Within one scientific family, Daniel J. Wallace focuses on topics pertaining to Gene expression under Immunology, and may sometimes address concerns connected to Interferon and Janus kinase.
Between 2017 and 2021, his most popular works were:
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus (197 citations)
- 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus (173 citations)
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial (171 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
His main research concerns Internal medicine, Lupus erythematosus, Systemic lupus erythematosus, Rheumatology and Young adult.
His studies link Anti-nuclear antibody with Internal medicine.
His Lupus erythematosus research includes themes of Predictive value of tests, Randomized controlled trial, Severity of illness and Monoclonal.
He has researched Systemic lupus erythematosus in several fields, including Quantitative trait locus, Prospective cohort study and Medical record.
The various areas that Daniel J. Wallace examines in his Rheumatology study include Autoantibody, Frailty Index and Hazard ratio.
The study incorporates disciplines such as Autoimmune disease, Disease, Incidence and Nephritis in addition to Young adult.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
